Replimune Group, Inc.'s RP1 + OPDIVO for advanced melanoma gains FDA Priority Review. PDUFA date: July 22, 2025. Read more on ...

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 ...

Lola, a 9-year-old golden retriever, was referred to UC Davis William R. Pritchard Veterinary Medical Teaching Hospital after ...

A groundbreaking new urine test could soon help spot the early warning signs of lung cancer long before symptoms appear.

Tamra Judge is one of Teddi Mellencamp's biggest supporters amid her cancer journey, so Mellencamp's wins are also Judge's ...

In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as ...

The former 'Real Housewives of Beverly Hills' star underwent emergency brain surgery earlier this year. Teddi Mellencamp is ...

Immunai will generate a publicly accessible multi-omic dataset for a Parker Institute cohort of over 1,000 cancer patients.

Teddi Mellencamp has given fans a new optimistic update on her cancer.

Teddi Mellencamp has shared a hopeful update in her cancer journey after revealing earlier this year that melanoma had spread ...

Amtagvi® and its accompanying design marks, Proleukin ®, Iovance ®, and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other ...